Tag: rare disease drugs
Orphan Drug Exclusivity: How Rare-Disease Medicines Get Market Protection
Nov, 29 2025
Orphan drug exclusivity gives pharmaceutical companies seven years of market protection for rare-disease treatments, encouraging development where profits are low. Learn how it works, why it's controversial, and how it compares to patents and global systems.